SCHEMBL24933459

SCHEMBL24933459

CSc1cccc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3CF)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.40
PARP10 Q53GL7 3/20 0.40
GSTP1 P09211 2/20 0.39
PARP15 Q460N3 3/20 0.39
PARP14 Q460N5 1/20 0.38
FFAR1 O14842 2/20 0.37
HDAC3 O15379 1/20 0.36
PARP1 P09874 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933475 0.79 PARP10 (0.42) MAOBPARP10GSTP1HDAC3PARP1
SCHEMBL24933352 0.76 MAOB (0.42) MAOBPARP10GSTP1FFAR1HDAC3
SCHEMBL24933199 0.73 MAOB (0.46) MAOBPARP10PARP15FFAR1ALDH1A1
SCHEMBL30240807 0.73 MAOB (0.46) MAOBPARP10PARP15FFAR1ALDH1A1
SCHEMBL24932976 0.72 MAOB (0.52) MAOBPARP10PARP15PARP14HDAC3
SCHEMBL30240782 0.72 MAOB (0.52) MAOBPARP10PARP15PARP14HDAC3
SCHEMBL30240765 0.72 MAOB (0.47) MAOBPARP10GSTP1PARP15PARP14
SCHEMBL24933362 0.72 MAOB (0.47) MAOBPARP10GSTP1PARP15PARP14
SCHEMBL24933615 0.72 MAOB (0.60) MAOBFFAR1FFAR4MAPTMAOA
SCHEMBL24933349 0.71 GSTP1 (0.50) MAOBPARP10GSTP1FFAR1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed